| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.47B | 82.86B | 84.19B | 81.76B | 94.44B | 81.75B |
| Gross Profit | 9.10B | 8.99B | 8.63B | 8.83B | 11.31B | 10.56B |
| EBITDA | 9.79B | 8.87B | 8.60B | 8.87B | 10.73B | 10.29B |
| Net Income | 3.53B | 3.50B | 3.33B | 3.67B | 5.36B | 5.05B |
Balance Sheet | ||||||
| Total Assets | 74.41B | 74.25B | 69.88B | 66.83B | 68.28B | 63.59B |
| Cash, Cash Equivalents and Short-Term Investments | 7.79B | 5.08B | 2.19B | 4.26B | 3.19B | 4.71B |
| Total Debt | 29.06B | 25.45B | 22.44B | 20.83B | 20.22B | 19.02B |
| Total Liabilities | 50.56B | 51.63B | 45.66B | 43.94B | 44.58B | 44.09B |
| Stockholders Equity | 23.40B | 22.23B | 23.79B | 22.48B | 23.24B | 19.04B |
Cash Flow | ||||||
| Free Cash Flow | 6.19B | 5.61B | 5.79B | 5.88B | 7.05B | 6.26B |
| Operating Cash Flow | 8.97B | 8.40B | 8.72B | 9.26B | 10.96B | 9.99B |
| Investing Cash Flow | -5.13B | -4.94B | -2.39B | -2.18B | -3.18B | -4.82B |
| Financing Cash Flow | -4.66B | -3.49B | -6.35B | -6.90B | -7.41B | -6.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €770.44M | 12.67 | 16.03% | 5.12% | -5.58% | -5.61% | |
67 Neutral | €57.31B | 16.26 | 16.07% | 3.97% | -2.69% | 7.84% | |
58 Neutral | €10.31B | 6.40 | 13.67% | 3.56% | 4.96% | 26.60% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | €6.66B | 14.80 | 8.46% | ― | 0.92% | 2.89% | |
53 Neutral | €19.51B | 81.59 | 4.94% | 7.14% | -10.66% | -90.22% | |
43 Neutral | €2.11B | 770.81 | 0.36% | 0.47% | 6.05% | -716.00% |